# Small extracellular vesicles enhance the survival of Sca-1+ cardiac stem cells against ROS-induced ischemic-reoxygenation injury in vitro

**Authors:** Radwa A. Mehanna, Hagar Elkafrawy, Marwa M. Essawy, Samar S. Ibrahim, Ashraf K. Awaad, Nehal A. Khalil, Marwa A. Kholief, Abeer Sallam, Heba A. Hamed, Mona A. Barkat, Mohamed F. ElKady, Eman H. Thabet

PMC · DOI: 10.1186/s40659-025-00593-7 · Biological Research · 2025-03-05

## TL;DR

This study shows that small extracellular vesicles from bone marrow stem cells protect heart stem cells from injury caused by oxygen deprivation and reoxygenation.

## Contribution

The study demonstrates that sEVs rich in miRNA-21-5p can precondition Sca-1+ cardiac stem cells to enhance their survival and regeneration under ischemic-reoxygenation stress.

## Key findings

- sEVs reduced apoptosis and increased proliferation in Sca-1+/CSCs under IR conditions.
- miRNA-21-5p-rich sEVs promoted cell cycle progression and stabilized HIF-1α expression.
- sEVs helped reduce oxidative stress and restore redox balance in treated cells.

## Abstract

Ischemic reperfusion (IR) generates reactive oxygen species (ROS) that inevitably result in myocardial cell death and heart failure. The regenerative power of cardiac progenitor/stem pools (CSCs), especially the Sca1+ population, in response to IR injury remains unclear.

Our work sought to investigate whether small extracellular vesicles (sEVs) isolated from bone marrow-mesenchymal stem cells (BMMSCs) could rescue CSCs, specifically Sca-1+/CSCs, from IR by increasing their proliferative capacity and limiting their apoptosis in vitro. The Sca-1+/CSCs-IR model was induced by the oxygen-glucose deprivation/reoxygenation method (OGD/R). The effects of treatment with BMMSCs-derived sEVs on oxidative stress, cell proliferation, apoptosis, and cell cycle were assessed. To further test the mechanistic action, we assessed the PTEN/pAkt/HIF-1α pathway.

Compared to hypoxic untreated CSCs, BMMSCs-derived sEVs-treated cells had shifted from their quiescent to proliferative phase (p > 0.05) and showed decreased apoptosis (p < 0.001). sEVs-treated CSCs were predominately in the S phase (11.8 ± 0.9%) (p < 0.01). We identified an abundance of miRNA-21-5P in BMMSCs. HIF-1α expression was highest in CSCs treated with sEVs (p < 0.05). Moreover, miRNA-21-5p-rich sEVs shifted the redox state, reducing oxidative stress and promoting balance (p > 0.05).

Conditioning Sca-1+/CSCs, an essential population in the postnatal heart, with sEVs rich in miRNA-21 robustly enhanced the proliferation, and synthesis phase of the cell cycle, and stabilized HIF-1α while alleviating oxidative stress and apoptosis. Such sEVs rich in miRNA-21-5p can be further used as a preconditioning tool to enhance endogenous Sca-1+/CSCs regeneration in response to IR injury.

The online version contains supplementary material available at 10.1186/s40659-025-00593-7.

## Linked entities

- **Genes:** CASP3 (caspase 3) [NCBI Gene 836], PTEN (phosphatase and tensin homolog) [NCBI Gene 5728], HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091]

## Full-text entities

- **Genes:** PTEN (phosphatase and tensin homolog) [NCBI Gene 5728] {aka 10q23del, BZS, CWS1, DEC, GLM2, MHAM}, MIR21 (microRNA 21) [NCBI Gene 406991] {aka MIRN21, hsa-mir-21, miR-21, miRNA21}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, MIR215 (microRNA 215) [NCBI Gene 406997] {aka MIRN215, miRNA215, mir-215}, ATXN1 (ataxin 1) [NCBI Gene 6310] {aka ATX1, D6S504E, SCA1}
- **Diseases:** hypoxic (MESH:D002534), heart failure (MESH:D006333), Ischemic (MESH:D002545)
- **Chemicals:** oxygen (MESH:D010100), ROS (MESH:D017382)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11881436/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11881436/full.md

## References

13 references — full list in the complete paper: https://tomesphere.com/paper/PMC11881436/full.md

---
Source: https://tomesphere.com/paper/PMC11881436